Home > Healthcare & Medical Devices > Clinical Nutrition Market

Clinical Nutrition Market Size By Product (Infant Nutrition {Milk Based, Soy Based, Organic Formulas}, Enteral Nutrition {Standard Composition, Disease Specific Composition}, Parenteral Nutrition {Amino Acids, Fats, Carbohydrates}), By Consumer (Pediatric, Adult), By Application (Cancer, Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), By Dosage Formulation (Powder, Liquid, Solid), Industry Analysis Report, Application Potential, Competitive Market Share & Forecast, 2023 - 2032

  • Report ID: GMI1324
  • Published Date: Jan 2023
  • Report Format: PDF

Industry Statistics

Clinical Nutrition Market size was valued at over USD 50.5 billion in 2022. Driven by the growing occurrence of metabolic disorders and numerous other chronic conditions worldwide, the market is expected to grow at over 10% CAGR from 2023 to 2032. 
 

Get more details on this report - Request Free Sample PDF
 

Surging prevalence of chronic conditions such as respiratory diseases, cardiovascular ailments, cancer, gastrointestinal disorders, and malnourishment among adults and children is elevating the need for nutritional support. Oropharyngeal dysphagia, while commonly observed among the geriatric population, is often also reported in patients suffering from neurological diseases such as multiple sclerosis, oropharyngeal dysphagia, Parkinson's disease, and dementia.
 

The swallowing problems caused by the condition are creating a strong impetus for clinical nutrition, especially as the disease load of neurological disorders continues to rise across the globe. As per a report published by WHO in 2022, the number of people suffering from dementia is likely to reach 78 million in 2030 and 139 million in 2050.
 

Strict regulatory scenario may dampen the clinical nutrition market outlook

Strict regulations governing the clinical nutrition landscape may hold back the industry scenario through 2032. In the US, the FDA regulates clinical nutrition products under a different set of guidelines than those covering drug products and conventional food items. Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), the FDA prohibits the sale of clinical nutrition products that are misbranded of adulterated in any way.
 

With patient lives on the line, manufacturers have to strictly adhere to the regulatory guidelines, and any type of alterations to the product compositions have to get approved by the governing body before commercialization can be commenced. This makes the cost of entry particularly high for newcomers in the sector.
 

Rising cases of pediatric gastrointestinal disorders to drive enteral nutrition segment expansion

Get more details on this report - Request Free Sample PDF
 

Based on product, the clinical nutrition market size from enteral nutrition segment was valued at more than USD 17.1 billion in 2022. Increasing cases of pediatric gastrointestinal disorders across the globe are likely to outline the market scenario. Enteral nutrition is usually prescribed to patients with partially functioning gut to effectively fulfil their energy as well as nutrient requirements. Often people with gastrointestinal disorders are not able to meet their day-to-day nutrition requirements through regular food intake, making enteral feeding integral for their health. This type of clinical nutrition is efficacious in most cases of GI disorders due to its ability to deliver enhanced patient outcomes without many complications.
 

Surging poverty and overpopulation globally to fuel pediatric consumer segment share

Based on consumer, clinical nutrition market from the pediatric consumer segment is slated to surpass USD 78.2 billion by 2032, driven by the surging prevalence of poverty and overpopulation in underdeveloped nations. Poverty and overpopulation is an unfortunate mix that often leads to malnourishment among children. As per the World Bank, more than 10 million people, approximately 41.8% of the population fell under the extreme poverty line in Niger, an underdeveloped West African country, in 2021.
 

Better product availability to spur distribution channel segment growth through retail stores

Authors: Rupali Swain, Subodh Kharad

Frequently Asked Questions (FAQ) :

The global market for clinical nutrition held a valuation of more than USD 50.5 billion in 2022 and is expected to grow at over 10% CAGR from 2023 to 2032, fueled by growing cases of chronic and metabolic disorders worldwide.
Pediatric segment is poised to surpass USD 78.2 billion by 2032, owing to rising prevalence of poverty and overpopulation in underdeveloped countries, leading to a higher rate of malnutrition.
Europe clinical nutrition market size is set to surpass USD 30.5 billion by 2032, owing to the growing number of cancer patients with nutritional deficiency in the region.
Some of the major leaders partaking in the market include names such as Fresenius Kabi, Baxter International Inc., Nestle Health Science, Mead Johnson (Reckitt Benckiser), Perrigo, Danone, and Pfizer, Inc., among others.

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 19
  • Tables & Figures: 679
  • Countries covered: 31
  • Pages: 330
  • Upcoming Report: Details can be customized to meet your information and data needs. Feel free to share your detailed research requirements via this form.

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount